Business Context and Reporting Period
This Form 8-K reports on the 2013 Annual Meeting of Stockholders for Alnylam Pharmaceuticals, Inc., held on June 6, 2013. The report details the outcomes of shareholder votes regarding director elections, equity plan amendments, executive compensation, and auditor ratification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
As of the record date (April 19, 2013), 62,139,891 shares were issued and outstanding. The following matters were voted upon:
- Director Elections: Stockholders re-elected three Class III directors (Victor J. Dzau, M.D., Steven M. Paul, M.D., and Kevin P. Starr) to serve until the 2016 annual meeting. All three received significant majority support with over 47 million votes "For" each.
- Stock Incentive Plan: Stockholders approved an amendment to the 2009 Stock Incentive Plan, increasing the authorized shares for issuance from 2,200,000 to 5,900,000. The vote was split, with 34,106,920 votes "For" and 14,331,809 votes "Against."
- Executive Compensation: In a non-binding advisory vote, stockholders approved the compensation of named executive officers with 46,031,937 votes "For" and 2,387,241 votes "Against."
- Auditor Ratification: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending December 31, 2013, with 52,305,509 votes "For" and 145,783 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the Annual Meeting results.
Investor Verification Checklist
- Verify the impact of the increased share authorization (from 2.2M to 5.9M) on potential future dilution.
- Review the specific terms of the 2009 Stock Incentive Plan amendment to understand vesting and eligibility criteria.
- Confirm the tenure of the re-elected Class III directors and the continuing terms of the other board members.
- Check subsequent filings for the company's financial performance for the fiscal year ending December 31, 2013, as this 8-K does not contain financial data.